<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23855" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Keratitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Prabhakar</given-names>
          </name>
          <aff>AIIMS, Kalyani</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Abhishek</given-names>
          </name>
          <aff>IGIMS</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prabhakar Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Abhishek Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23855.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Keratitis is a clinical entity wherein inflammatory cells infiltrate different corneal layers in response to noxious stimuli, either infectious exogenous agents or self-antigens. The inflammatory reaction may result in the suppurative melting of corneal epithelium and stroma, resulting in the formation of ulcers. This results not only in the loss of corneal clarity but also threatens the integrity of the globe. Such cases may result in corneal blindness. This activity helps clinicians identify the etiological agent at the earliest based on clinical features and appropriate diagnostic tests and manage these patients with the latest treatment options. It reviews the role of the interprofessional team.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review different types of keratitis</p></list-item><list-item><p>Outline the appropriate evaluation of keratitis.</p></list-item><list-item><p>Summarize the management options available for keratitis.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to advance the care of keratitis and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23855&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23855">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23855.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Keratitis is the inflammation of the cornea and is characterized by corneal edema, infiltration of inflammatory cells, and ciliary congestion. It&#x000a0;is associated with both infectious and noninfectious diseases, which may be systemic or localized to the ocular surface. Amongst the types of keratitis discussed above, "microbial keratitis" accounts for the majority and is primarily a cause of major concern in developing countries. However, noninfectious keratitis can not be looked down upon, especially in developed nations.</p>
        <p>Our first line of defense is strong enough to dispel most of the infection, causing insults; however, there exist some organisms that can evade this line and cause infection. The corneal epithelium is one such barrier. Most of the organisms cannot penetrate intact epithelium, so they cannot incite keratitis in the absence of cellular injury. <italic toggle="yes">Neisseria meningitides, N. gonorrhea, Corynebacterium diphtheria,&#x000a0;Haemophilus influenzae, </italic>and<italic toggle="yes">&#x000a0;Listeria species&#x000a0;</italic>are virulent organisms with the potential to penetrate even intact epithelium and cause keratitis.<xref ref-type="bibr" rid="article-23855.r1">[1]</xref>&#x000a0;This article discusses the etiology and available current and future management options for different types of keratitis.</p>
      </sec>
      <sec id="article-23855.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Based on the etiological agent, keratitis can be classified as:</p>
        <p>
<bold>Infectious Keratitis</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacterial keratitis - including&#x000a0;<italic toggle="yes">Pseudomonas, Staphylococcus, Streptococcus, Moraxella, Nocardia,</italic>&#x000a0;and Atypical<italic toggle="yes"> Mycobacteria</italic></p>
          </list-item>
          <list-item>
            <p>Protozoal keratitis - including&#x000a0;<italic toggle="yes">Acanthamoeba</italic></p>
          </list-item>
          <list-item>
            <p>Keratitis by Oomycete -&#x000a0;<italic toggle="yes">Pythium&#x000a0;</italic>keratitis.&#x000a0;Morphologically, very similar to fungi; however, unlike fungi, the cell wall here contains (1-3)(1-6) beta D glucan<xref ref-type="bibr" rid="article-23855.r2">[2]</xref><xref ref-type="bibr" rid="article-23855.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Fungal keratitis - This includes infection by&#x000a0;<italic toggle="yes">Aspergillus, Fusarium, Candida (yeast), Cladosporium, Alternaria, Curvularia,</italic>&#x000a0;and <italic toggle="yes">Microsporidia</italic></p>
          </list-item>
          <list-item>
            <p>Viral keratitis - This includes infection by&#x000a0;<italic toggle="yes">Herpes simplex virus (HSV), Herpes zoster virus (HZV), Adenovirus, and others.</italic></p>
          </list-item>
          <list-item>
            <p>Helminths-&#x000a0;<italic toggle="yes">Onchocercal keratitis</italic> (sclerosing keratitis).</p>
          </list-item>
        </list>
        <p>
<bold>Non-infectious Keratitis</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Local causes - include trichiasis, giant papillae, foreign body in sulcus subtarsalis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Peripheral ulcerative&#x000a0;keratitis&#x000a0;
<list list-type="bullet"><list-item><p>Collagen vascular diseases, like rheumatoid arthritis, granulomatosis with polyangiitis, polyarteritis nodosa, relapsing polychondritis, systemic lupus erythematosus, and others<xref ref-type="bibr" rid="article-23855.r4">[4]</xref>&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Neurotrophic&#x000a0;corneal ulcer (post-herpes zoster ophthalmicus, trigeminal nerve damage due to surgery or tumor)<xref ref-type="bibr" rid="article-23855.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Xerophthalmia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23855.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In an epidemiological study in California, the incidence of ulcerative keratitis was found to be 27.6/100000 person-years.<xref ref-type="bibr" rid="article-23855.r5">[5]</xref> Ulcerative keratitis was significantly higher among contact lens wearers.<xref ref-type="bibr" rid="article-23855.r5">[5]</xref></p>
        <p>As per a study conducted in South India, middle-aged males were more likely to get&#x000a0;corneal ulcers&#x000a0;compared to females.<xref ref-type="bibr" rid="article-23855.r6">[6]</xref>&#x000a0;Farmers are at high risk on account of their occupation. Fungal corneal ulcers are very common in developing nations. However, HSV is a major concern in&#x000a0;developed nations.<xref ref-type="bibr" rid="article-23855.r7">[7]</xref>&#x000a0;In an epidemiological study in Rochester, Minnesota, the incidence of epithelial disease was 15.6/100000 person-years, and for stromal keratitis, it was 2.6/100000 person-years.<xref ref-type="bibr" rid="article-23855.r8">[8]</xref></p>
        <p>Autoimmune disorders related to keratitis account for an estimated incidence of 3 per million per year.<xref ref-type="bibr" rid="article-23855.r9">[9]</xref></p>
        <p>The prevalence of xerophthalmia was almost 21% in a study in rural Ethiopia and was largely associated with other features of generalized malnutrition.<xref ref-type="bibr" rid="article-23855.r10">[10]</xref>&#x000a0;For xerophthalmia, the population at risk is largely young children who are malnourished.</p>
      </sec>
      <sec id="article-23855.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Stages of Corneal Ulcer</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage of progressive infiltration</p>
          </list-item>
          <list-item>
            <p>Stage of&#x000a0;active&#x000a0;ulceration</p>
          </list-item>
          <list-item>
            <p>Stage of regression</p>
          </list-item>
          <list-item>
            <p>Stage of cicatrization</p>
          </list-item>
        </list>
        <p>
<bold>Infectious Keratitis</bold>
</p>
        <p>Infection incites the recruitment of polymorphonuclear leukocytes and macrophages. The hydrolases and proteases released by these inflammatory cells are primarily responsible for corneal stromal melt and necrosis.<xref ref-type="bibr" rid="article-23855.r11">[11]</xref>&#x000a0;In gram-negative infections, endotoxin plays a major role and adds to the inflammatory response.</p>
        <p>
<bold>Adenoviral Keratoconjunctivitis</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 1 lasts 7 to 10 days and is characterized by diffuse punctate epithelial keratitis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Stage 2- After 7 days, subepithelial to anterior stromal infiltrates appear. NK cells are the first to come into action and further involve cell-mediated immunity.<xref ref-type="bibr" rid="article-23855.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Stage 3- This is characterized by persistent subepithelial to anterior stromal infiltrates.</p>
          </list-item>
        </list>
        <p>
<bold>Onchocerca Volvulus Induced Keratitis</bold>
</p>
        <p>Corneal infection by&#x000a0;motile worms does not per se cause blindness; however, as they die after chemotherapy or naturally, they incite inflammation and cause corneal punctate opacification. Repeated episodes result in complete opacification of the cornea and result in blindness.</p>
        <p>
<bold>Peripheral Ulcerative Keratitis</bold>
</p>
        <p>The exact etiology is not clear; however, both cell-mediated and humoral immunity play an important role. In response to a corneal antigen, the immune complex gets deposited in the peripheral cornea. The hypersensitivity reaction to an exogenous antigen is other described mechanisms.<xref ref-type="bibr" rid="article-23855.r13">[13]</xref></p>
        <p>
<bold>Xerophthalmia</bold>
</p>
        <p>Vitamin A is needed for the maintenance and integrity of the epithelial lining of the ocular surface. The loss of epithelial lining with subsequent liquefactive necrosis of the cornea results in&#x000a0;keratomalacia.</p>
      </sec>
      <sec id="article-23855.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Corneal infections often start as epithelial ulceration. This is followed by stromal infiltration by polymorphonuclear (PMN) and lymphomononuclear cells, which in turn causes the destruction of Bowman's layer and then stromal necrosis. In severe cases, there can be perforation of the Descemet's membrane. Suppurative infections lead to infiltrates in the anterior two-thirds of the stroma and abscess formation. Epithelial regeneration, vascularization, edema, giant cell reaction, myofibroblatic transformation and stromal remodeling (scarring), and round cell infiltration can occur with chronic infections.</p>
      </sec>
      <sec id="article-23855.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The most common complaints of patients with keratitis include redness, pain, and irritation in the eye. The patients may also&#x000a0;present with&#x000a0;photophobia, visual decline, or cosmetic blemish.&#x000a0;</p>
        <p>
<bold>Bacterial Keratitis</bold>
</p>
        <p>Keratitis by gram-positive organisms: Staphylococcal keratitis can be either because of direct invasion of the organism or because of staphylococcal antigen. Staphylococcal antigen-induced keratitis usually affects the peripheral cornea, hence the name 'marginal keratitis.' Marginal keratitis is invariably associated with staphylococcal blepharitis. The corneal lesions usually start at 10, 2, 4, and 8 o'clock positions, where the lid margin is in contact with the limbus. There is always a clear area between the limbus and the ulcerative lesion, unlike HSV marginal keratitis.&#x000a0;</p>
        <p>The most common cause of Streptococcal keratitis is a blocked nasolacrimal duct. So, lacrimal duct patency or regurgitation on pressure over the lacrimal sac (ROPLAS) should be&#x000a0;evaluated&#x000a0;in corneal ulcer cases.&#x000a0;</p>
        <p>In early-stages of Gram-positive infection, the cuff&#x000a0;of cellular infiltration is noted around the corneal focus of infection and is not diffuse, unlike Pseudomonal keratitis.</p>
        <p>Pseudomonas keratitis: In early-stage, diffuse and dense corneal cellularity is noted much beyond the focus of infection. Pseudomonas is a gram-negative bacteria with predominantly greenish-yellow corneal infiltrate and extensive collagenolysis.<bold>&#x000a0;</bold>The symptoms are more acute and rapidly progressive. Corneal melt might progress to corneal perforation or endophthalmitis if not taken care of in the early stages.&#x000a0;</p>
        <p>Nocardia keratitis: Nocardia is a weakly acid-fast bacteria (Modified Kinyoun stain).<xref ref-type="bibr" rid="article-23855.r14">[14]</xref>&#x000a0;There&#x000a0;may be a history of either trauma or intraocular surgery with corneal infiltrates usually starting adjacent to the surgical incision site. The infiltrates are granular, superficial to mid-stromal, with a wreath-like pattern often in the mid-peripheral cornea.<xref ref-type="bibr" rid="article-23855.r15">[15]</xref>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
        <p>Atypical mycobacteria: The Atypical mycobacteria are acid-fast bacilli causing keratitis with a protracted course. There&#x000a0;may be a history of trauma with corneal foreign bodies or a history of corneal surgery (LASIK).<xref ref-type="bibr" rid="article-23855.r16">[16]</xref>&#x000a0;The onset of keratitis in trauma cases can vary from days to weeks; however, post-LASIK cases usually have an average time of presentation of 3.4 weeks.<xref ref-type="bibr" rid="article-23855.r17">[17]</xref>&#x000a0; The disease has a waxing and waning course.<xref ref-type="bibr" rid="article-23855.r18">[18]</xref>&#x000a0;The corneal infiltrate has a typical cracked windshield appearance with radiating lines in the middle one-third of the corneal stroma.<xref ref-type="bibr" rid="article-23855.r19">[19]</xref></p>
        <p>
<bold>Viral Keratitis</bold>
</p>
        <p>Adenoviral keratitis: Adenoviral keratitis often has associated conjunctivitis, so the exact terminology would be Epidemic adenoviral keratoconjunctivitis (Human adenovirus types 8,19,37 and 54). Presentation is usually unilateral; however, it becomes bilateral later. A predominantly follicular reaction is noted.<xref ref-type="bibr" rid="article-23855.r20">[20]</xref>&#x000a0;It may or may not be associated with conjunctival hemorrhages.<xref ref-type="bibr" rid="article-23855.r21">[21]</xref>&#x000a0;At times, the inflammation can be severe enough, resulting in the formation of pseudomembranes. Clinically, corneal epitheliopathy develops, manifesting as punctate corneal erosions, which over a week develop into multiple punctate to nummular anterior stromal infiltrates.<xref ref-type="bibr" rid="article-23855.r21">[21]</xref><xref ref-type="bibr" rid="article-23855.r22">[22]</xref>&#x000a0;Preauricular lymphadenopathy is an important finding in adenoviral keratoconjunctivitis. In the pharyngoconjunctival variant (human adenovirus types 3,4, and 7), the patient may have systemic findings like pharyngitis and fever.&#x000a0;The corneal findings in the early stage (subepithelial to anterior stromal infiltrate) are considered to be due to active viral replication; however, in the chronic stage, the infiltrates are the result of an immunological reaction.<xref ref-type="bibr" rid="article-23855.r21">[21]</xref>&#x000a0;In the chronic stage, symblepharon can also be seen.<xref ref-type="bibr" rid="article-23855.r23">[23]</xref><xref ref-type="bibr" rid="article-23855.r24">[24]</xref><bold>&#x000a0;</bold>The patients at this stage often complain of photophobia, glare, and haloes.</p>
        <p>Herpes simplex keratitis: HSV keratitis can present as epithelial disease, stromal keratitis, and endotheliitis.<xref ref-type="bibr" rid="article-23855.r25">[25]</xref>&#x000a0;HSV epithelial disease manifestation may vary from multiple punctate erosions&#x000a0;to dendritic ulcers and geographical ulcers. The&#x000a0;early vesicular stage is often missed because of delayed presentation to the ophthalmic clinic. The ruptured vesicles coalesce together to form dendrites with a terminal bulb.<xref ref-type="bibr" rid="article-23855.r26">[26]</xref>&#x000a0;Inappropriate and indiscriminate use of topical steroids may result in geographical ulcer formation. In epithelial disease, the virus is actively involved in the causation of the ulcer.<xref ref-type="bibr" rid="article-23855.r27">[27]</xref>&#x000a0;HSV epithelial disease is usually unilateral, but the bilateral disease is more commonly seen in immunodeficient and patients with a history of atopy.<xref ref-type="bibr" rid="article-23855.r28">[28]</xref>&#x000a0;HSV stromal keratitis can either be secondary&#x000a0;to epithelial disease due to contiguous spread or immune-mediated.&#x000a0;If&#x000a0;stromal keratitis develops secondary to epithelial disease, an overlying epithelial defect is present. However, the primary stromal involvement manifests as localized stromal edema with or without signs of previous similar episodes. On resolution, these result in scar formation. These scars with vascularization are the telltale signs and&#x000a0;are also called 'footprint scars' with or without superficial or deep vascularization. HSV endotheliitis manifests as localized or diffuse stromal edema with underlying keratic precipitates.</p>
        <p>HSV necrotizing stromal keratitis is a variant where both the viral load and the&#x000a0;inflammatory component play roles simultaneously.<xref ref-type="bibr" rid="article-23855.r29">[29]</xref><xref ref-type="bibr" rid="article-23855.r30">[30]</xref>&#x000a0;It manifests as corneal stromal infiltrate with extensive collagenolysis and corneal thinning. If not treated early, corneal perforation&#x000a0;is likely.<xref ref-type="bibr" rid="article-23855.r31">[31]</xref>&#x000a0;</p>
        <p>Herpes zoster keratitis: The diagnosis&#x000a0;of Herpes zoster ophthalmicus (HZO) is very obvious. Associated&#x000a0;unilateral rashes over the forehead and eyelids with rashes reaching the tip of the nose (Hutchinson's sign) suggest likely involvement of the corresponding eye also.<xref ref-type="bibr" rid="article-23855.r32">[32]</xref>&#x000a0;Corneal dendritiform lesions with absent terminal bulbs are very characteristic.<xref ref-type="bibr" rid="article-23855.r33">[33]</xref><xref ref-type="bibr" rid="article-23855.r34">[34]</xref>&#x000a0;These lesions are due to direct invasion of epithelial cells.<xref ref-type="bibr" rid="article-23855.r35">[35]</xref>&#x000a0;It can also manifest as stromal&#x000a0;involvement&#x000a0;corresponding to the areas of epithelial pseudodendrites or deep stromal involvement.&#x000a0;Isolated stromal involvement&#x000a0;is largely an immunological reaction. It may or may not be associated with anterior chamber reaction. Associated trabeculitis manifests as raised intraocular pressure. Corneal sensations decrease significantly after HZO, resulting in recurrent corneal erosions in the chronic phase. The epitheliopathy may result in persistent epithelial defects and subsequent stromal ulceration. The ulcer is&#x000a0;called a 'neurotrophic ulcer.'<xref ref-type="bibr" rid="article-23855.r35">[35]</xref>&#x000a0;</p>
        <p>Thus, the absent&#x000a0;terminal bulbs and poor fluorescein uptake by the ulcer base differentiate&#x000a0;HZO keratitis from HSV keratitis.&#x000a0;</p>
        <p>
<bold>Protozoal Keratitis</bold>
</p>
        <p>Acanthamoeba keratitis: A history of exposure to soil or contaminated water is very often seen in Acanthamoeba keratitis in the developing world. However, in developed countries, contact lens wear has been found to have a strong association with Acanthamoeba keratitis. The spectrum of clinical features can vary from superficial punctate keratitis and pseudo-dendrites to peri-neuritis in the early stages.<xref ref-type="bibr" rid="article-23855.r36">[36]</xref>&#x000a0;Ring infiltrates are very characteristically seen in Acanthamoeba keratitis; however, this is not present in all cases.<xref ref-type="bibr" rid="article-23855.r36">[36]</xref>&#x000a0;As the disease progresses, the infiltrates extend from anterior to mid to full-thickness infiltrate and become indistinguishable from bacterial and fungal keratitis.<xref ref-type="bibr" rid="article-23855.r37">[37]</xref>&#x000a0;</p>
        <p>
<bold>Keratitis by Oomycetes</bold>
</p>
        <p>Pythium keratitis: This keratitis is caused by an oomycete, a distinct phylogenetically related lineage of fungus-like eukaryotic microorganisms.&#x000a0;<italic toggle="yes">Pythium insidiosum</italic>&#x000a0;species causes disease in humans. The corneal lesions often mimic fungal infiltrate, and careful examination reveals dry-looking corneal infiltrates denser in the periphery of the whole infiltration with hyphate edges. Pin-head-like lesions and tentacular extensions of the main lesion are very characteristic of Pythium keratitis.<xref ref-type="bibr" rid="article-23855.r38">[38]</xref></p>
        <p>
<bold>Fungal Keratitis</bold>
</p>
        <p>Microsporidial keratitis: Previously, microsporidia was considered to be a primitive protozoan.<xref ref-type="bibr" rid="article-23855.r39">[39]</xref>&#x000a0;However, subsequently, molecular phylogenetic studies revealed that it belonged to fungi.<xref ref-type="bibr" rid="article-23855.r40">[40]</xref><xref ref-type="bibr" rid="article-23855.r41">[41]</xref>&#x000a0;&#x000a0;Microsporidial keratitis can be classified as 'keratoconjunctivitis' and 'deep stromal keratitis.' The former is more commonly seen in immunocompromised but can also be seen in immunocompetent.<xref ref-type="bibr" rid="article-23855.r42">[42]</xref><xref ref-type="bibr" rid="article-23855.r43">[43]</xref><xref ref-type="bibr" rid="article-23855.r44">[44]</xref>&#x000a0;The onset of keratoconjunctivitis is usually acute. A rise in keratoconjunctivitis cases is noted during the rainy season.<xref ref-type="bibr" rid="article-23855.r45">[45]</xref><xref ref-type="bibr" rid="article-23855.r46">[46]</xref>&#x000a0;Exposure to muddy water is an important predisposing cause.<xref ref-type="bibr" rid="article-23855.r47">[47]</xref>&#x000a0;In keratoconjunctivitis, multiple punctate, coarse, and raised epithelial lesions with stuck-on appearance are noted. During its course, subepithelial infiltrates might appear, mimicking adenoviral keratoconjunctivitis. The conjunctiva shows predominantly follicular response, though papillary reactions are also apparent. Mild anterior chamber reaction with keratic precipitates can be seen.<xref ref-type="bibr" rid="article-23855.r48">[48]</xref>&#x000a0;The deep stromal variant has a chronic course of waxing and waning. The stromal infiltrates are deep with intact overlying epithelium. The course can vary from months to years.<xref ref-type="bibr" rid="article-23855.r49">[49]</xref><xref ref-type="bibr" rid="article-23855.r50">[50]</xref></p>
        <p>Filamentous fungal keratitis: A history of trauma with vegetative matter is very often noted. Corneal infiltrates in fungal keratitis are usually dry-looking and have feathery edges with the presence of multiple satellite lesions. Plaque-like (with or without pigmentation) or fungal ball-like surface lesions can also be very commonly seen. At times, the retained corneal vegetative foreign body lies in close association with the infiltrate. Endothelial plaque or exudates in the absence of anterior stromal infiltrate can also be seen. In such a scenario, careful examination often reveals a track from the anterior corneal surface to the endothelium. This track is usually the path of entry for fungal infection and usually follows penetrating trauma. The hypopyon is usually thick and does not shift with a change in head position. The course of the disease is usually longer. Compared to bacterial keratitis, the outcomes of fungal keratitis are poor.<xref ref-type="bibr" rid="article-23855.r51">[51]</xref><xref ref-type="bibr" rid="article-23855.r52">[52]</xref></p>
        <p><italic toggle="yes">Alternaria</italic>&#x000a0;sp.,&#x000a0;<italic toggle="yes">Bipolaris</italic>&#x000a0;sp., and&#x000a0;<italic toggle="yes">Curvularia</italic>&#x000a0;sp.&#x000a0;are the pigmented fungal species causing infections in humans. The infiltrate may have pigmentation (brown)&#x000a0;in dematiaceous fungal keratitis.<xref ref-type="bibr" rid="article-23855.r53">[53]</xref></p>
        <p>Candida keratitis: Clinical features are indistinguishable from fungal keratitis.</p>
        <p>Onchocerca volvulus keratitis: This results in sclerosing keratitis. Corneal opacity starts from the periphery, and the visual axis gets affected at last. Deep vascularization is noted at 360 degrees.&#x000a0;</p>
        <p>
<bold>Non-infectious Keratitis&#x000a0;</bold>
</p>
        <p>
<bold>Local Causes</bold>
</p>
        <p>Trichiatic eyelashes, giant papillae, or any foreign body lodged in the sulcus subtarsalis can result in persistent epithelial denudation mechanically and subsequent stromal ulceration. To start with, these corneal epithelial defects are usually sterile; however, they can get secondarily infected. Ulcers due to trichiatic lashes are very often seen&#x000a0;as sequelae of cicatrizing conjunctivitis. The corneal ulcers in trichiatic lashes of the lower lid are usually present in the lower half of the cornea.<xref ref-type="bibr" rid="article-23855.r54">[54]</xref>&#x000a0;</p>
        <p>Patients with severe allergic conjunctivitis often develop giant papillae and can result in the formation of an ulcer on superior half of cornea called "Shield ulcer." Patients&#x000a0;will give a history of previous allergic eye disease.</p>
        <p>In both<bold>&#x000a0;</bold>the cases mentioned above, the onset of ulcer development will be gradual.</p>
        <p>Patients with a foreign body in the sulcus subtarsalis often have a short history and an acute onset of symptoms. They usually give a history of the foreign body's fall into the eye. On careful examination, multiple linear abrasions in the superior cornea may also be very obvious.<xref ref-type="bibr" rid="article-23855.r55">[55]</xref>&#x000a0;Fluorescein stain accentuates the appearance and may show these abrasions&#x000a0;clearly.</p>
        <p>
<bold>Systemic Causes</bold>
</p>
        <p>Various systemic causes can alter the local ocular surface milieu and subsequently cause severe dry eye and keratitis.[56] Connective tissue diseases are an important risk factor for keratitis.&#x000a0;</p>
        <p>Rheumatoid arthritis (RA): RA is known to cause a spectrum of ocular abnormalities. Severe dry eye, scleritis, sclerokeratitis, and peripheral ulcerative keratitis are various manifestations of the disease.<xref ref-type="bibr" rid="article-23855.r56">[56]</xref>&#x000a0;A history of small joint pain with or without finger deformities are important clue to reach the diagnosis.<xref ref-type="bibr" rid="article-23855.r57">[57]</xref>&#x000a0;If systemic findings are not picked up in time, these cases can end up in corneal perforations or severe systemic disease.&#x000a0;</p>
        <p>Wegner granulomatosis (WG)/granulomatosis with polyangiitis: WG is&#x000a0;a connective tissue disorder (necrotizing vasculitis) that is known to cause keratitis, episcleritis, and scleritis.<xref ref-type="bibr" rid="article-23855.r58">[58]</xref>&#x000a0;The patient can present with peripheral ulcerative keratitis.<xref ref-type="bibr" rid="article-23855.r59">[59]</xref><xref ref-type="bibr" rid="article-23855.r60">[60]</xref>&#x000a0;A careful examination might reveal a depressed nasal bridge or destruction of the pinna of the ear.<xref ref-type="bibr" rid="article-23855.r61">[61]</xref>&#x000a0;History of nasal bleeding and hemoptysis can also be elicited. Here, early diagnosis is important to decrease not only morbidity but also mortality.</p>
        <p>Other systemic conditions resulting in keratitis are also known, such as systemic lupus erythematosus, relapsing polychondritis, and polyarteritis nodosa. Careful history-taking helps to diagnose these conditions.</p>
        <p>Xerophthalmia: The keratolysis in xerophthalmia results in a punched-out corneal ulcer that has a high propensity to perforate if left untreated.[62] The fellow eye will have a dull and lustreless cornea with conjunctival signs like Bitot's spot and conjunctival xerosis. A history of recent-onset&#x000a0;exanthematous fever or diarrhea can be elicited. Other evidence of malnutrition may be present.</p>
      </sec>
      <sec id="article-23855.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Regurgitation on pressure over the lacrimal sac area (ROPLAS) and/or sac syringing constitute an important routine investigation in all corneal ulcer patients to rule out obstructed nasolacrimal duct-induced keratitis. The routine protocol for any corneal ulcer is to look for the characteristic features of the ulcer, followed by corneal scraping to identify the causative organism.<xref ref-type="bibr" rid="article-23855.r62">[62]</xref>&#x000a0;The sample is sent for slides and culture with sensitivity. Commonly, two slides are prepared, one each for Gram staining and 10% KOH mount.<xref ref-type="bibr" rid="article-23855.r63">[63]</xref>&#x000a0;</p>
        <p>The patient is started on medications based on direct microscopy findings, and subsequently, the treatment is further modified based on culture reports. Commonly used culture media are blood and chocolate agar for bacterial growth. Potato dextrose agar and <italic toggle="yes">Saboraud's</italic> dextrose agar are used for fungal growth and non-nutrient agar with <italic toggle="yes">E. coli&#x000a0;</italic>for <italic toggle="yes">Acanthamoeba.</italic><xref ref-type="bibr" rid="article-23855.r64">[64]</xref>&#x000a0;Specific&#x000a0;microbiological&#x000a0;features have been discussed in the management section.&#x000a0;</p>
        <p>Serology forms the basis for the diagnosis of autoimmune diseases. However, the diagnosis of xerophthalmia is largely clinical.</p>
      </sec>
      <sec id="article-23855.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Bacterial Keratitis</bold>
</p>
        <p>For bacterial keratitis, patients are started on fortified topical antibiotics empirically until culture reports are available. Fortified cefazolin 5% or vancomycin and fluoroquinolones or tobramycin or gentamicin give complete coverage against both gram-positive and gram-negative organisms. For keratitis caused by methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA), topical vancomycin is the drug of choice.<xref ref-type="bibr" rid="article-23855.r65">[65]</xref> Topical linezolid 0.2% can also be used for MRSA.&#x000a0;</p>
        <p>Pseudomonas Keratitis: Direct smears on Grams staining show gram-negative rods and culture grows <italic toggle="yes">Pseudomonas aeruginosa.&#x000a0;</italic>The patient is started on topical fluoroquinolones hourly.&#x000a0;Treatment is modified once the culture and sensitivity report is available. Oral doxycycline is added to halt the progression of collagenolysis.<xref ref-type="bibr" rid="article-23855.r66">[66]</xref>&#x000a0;For resistant strains, topical imipenem-cilastatin (1%) or colistin (0.19%) is being used.<xref ref-type="bibr" rid="article-23855.r67">[67]</xref></p>
        <p>Nocardia Keratitis:&#x000a0; Corneal smears are subjected to routine Gram staining and 1% acid-fast staining.<xref ref-type="bibr" rid="article-23855.r68">[68]</xref>&#x000a0;Nocardia is a gram-positive, aerobic bacillus with thin beaded filaments exhibiting extensive branching at 90&#x000b0;.<xref ref-type="bibr" rid="article-23855.r69">[69]</xref>&#x000a0;Nocardia grows well on conventional culture media, though slower than other organisms. Topical fortified amikacin (2.5%) is the treatment of choice.<xref ref-type="bibr" rid="article-23855.r15">[15]</xref>&#x000a0;Pre-treatment with topical steroids worsens the prognosis.<xref ref-type="bibr" rid="article-23855.r70">[70]</xref></p>
        <p>Atypical mycobacteria: Ziehl Neelsen stain is used to identify the organism in smears. Topical fortified amikacin (4%) is the treatment of choice.<xref ref-type="bibr" rid="article-23855.r18">[18]</xref>&#x000a0;Clarithromycin (2%) is the second line of management. However, fluoroquinolones (ciprofloxacin 0,3%)&#x000a0;can also be used.&#x000a0;</p>
        <p>
<bold>Protozoal Keratitis</bold>
</p>
        <p>A clinician needs to have strong suspicion for making a diagnosis of&#x000a0;<italic toggle="yes">Acanthamoeba&#x000a0;</italic>keratitis based on the history and clinical features. Previous topical steroid use might increase the yield of the organism in smears and culture; however, it worsens the prognosis. As the clinical picture often mimics viral keratitis, pre-treatment with antivirals may alter the clinical picture. In Gram staining, the cysts are visible as multiple double-walled cysts with inner polyhedral lining. 10% KOH-mount and 10% KOH with 0.1% calcofluor white also demonstrate&#x000a0;<italic toggle="yes">Acanthamoeba&#x000a0;</italic>cysts.&#x000a0;Non-nutrient agar seeded with&#x000a0;<italic toggle="yes">E.coli</italic> is used for culture. Biguanides and pentamidine are the mainstays of treatment.<xref ref-type="bibr" rid="article-23855.r71">[71]</xref>&#x000a0;Polyhexamethylene biguanide (PHMB)&#x000a0;(0.02%) and chlorhexidine (0.02%) are commonly used biguanides. Monotherapy with one drug is quite effective. Studies suggest a synergistic effect of biguanide (PHMB and chlorhexidine) and pentamidine. The role of voriconazole and BAK (preservative) is under investigation.<xref ref-type="bibr" rid="article-23855.r72">[72]</xref>&#x000a0;The role of endosymbiont bacteria (<italic toggle="yes">Pseudomonas aeruginosa)&#x000a0;</italic>in the development of acanthamoeba keratitis has also been described.<xref ref-type="bibr" rid="article-23855.r73">[73]</xref>&#x000a0;The role of the addition of levofloxacin to the anti-protozoal treatment regimen might&#x000a0;facilitate treatment&#x000a0;in resistant cases.<xref ref-type="bibr" rid="article-23855.r74">[74]</xref>&#x000a0;For non-responding cases, deep anterior lamellar keratoplasty is a valid option. For cases with perforation, penetrating keratoplasty is the only option, but with poor prognosis.</p>
        <p>
<bold>Keratitis by Oomycete</bold>
</p>
        <p><italic toggle="yes">Pythium insidiosum</italic> on&#x000a0;Gram staining and 10% KOH with 0.1% calcofluor white show fungus-like broad aseptate filaments with ribbon-like folds.<xref ref-type="bibr" rid="article-23855.r38">[38]</xref>&#x000a0;Zoospore induction helps in identification, and Internal Transcribed Spacer DNA sequencing&#x000a0;helps in confirmation.<xref ref-type="bibr" rid="article-23855.r38">[38]</xref>&#x000a0;Iodine-potassium-iodide-sulphuric acid stain (IKI-H2SO4)&#x000a0;has been described as another&#x000a0;way of staining that is said to be exclusive for&#x000a0;<italic toggle="yes">Pythium insidiosum</italic> and may&#x000a0;help in early diagnosis<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-23855.r75">[75]</xref>&#x000a0;Various studies are being done to establish diagnosis using confocal microscopy; however,&#x000a0;results are inconclusive. Hourly administration of topical linezolid (0.2%) along with topical (1% every 2 hours) and oral azithromycin<bold>&#x000a0;</bold>(500mg daily for 3 days in a week)&#x000a0;was found to be effective in treating keratitis in the earliest report.<xref ref-type="bibr" rid="article-23855.r76">[76]</xref>&#x000a0;The favorable role of these agents in&#x000a0;<italic toggle="yes">Pythium keratitis</italic> was further substantiated by Bagga et al. in their&#x000a0;study of these agents over 3 years.<xref ref-type="bibr" rid="article-23855.r77">[77]</xref>&#x000a0;However, in-vitro susceptibility of&#x000a0;<italic toggle="yes">Pythium insidiosum</italic>&#x000a0;to minocycline and tigecycline was also fairly acceptable.<xref ref-type="bibr" rid="article-23855.r78">[78]</xref></p>
        <p>
<bold>Fungal Keratitis</bold>
</p>
        <p>Microsporidial keratitis: Microsporodial spores stain well with Grams, silver, and 10% potassium hydroxide (KOH) with 0.1% calcofluor white. The keratoconjunctivitis variant has a self-limiting course.<xref ref-type="bibr" rid="article-23855.r79">[79]</xref>&#x000a0;Topical lubricants can be added to palliate the foreign body sensation. Epithelial debridement is also a valid option for the early resolution of corneal lesions.<xref ref-type="bibr" rid="article-23855.r80">[80]</xref>&#x000a0;The deep stromal variant is unlikely to respond to conservative management with oral albendazole (400 mg twice daily for 3-4 weeks) and topical fumagillin (topical, 70 mcg/ml, 2 drops every 2 h for 4 days and then 2 drops 4 times daily).<xref ref-type="bibr" rid="article-23855.r81">[81]</xref><xref ref-type="bibr" rid="article-23855.r82">[82]</xref><xref ref-type="bibr" rid="article-23855.r81">[81]</xref>&#x000a0;Therapeutic penetrating keratoplasty is the treatment of choice.<xref ref-type="bibr" rid="article-23855.r50">[50]</xref></p>
        <p>Filamentous fungal keratitis: Routine microscopy with 10% KOH alone or 10% KOH with 0.1% calcofluor white reveals hyaline/ pigmented, septate (Aspergillus, <italic toggle="yes">Fusarium</italic>)/ aseptate (<italic toggle="yes">Mucor, Rhizopus</italic>) fungal filaments. Preferred culture media for fungal growth are Saboraud's and potato dextrose agar. Topical natamycin<bold>&#x000a0;</bold>(5%)&#x000a0;is the drug of choice for filamentous fungal keratitis.<xref ref-type="bibr" rid="article-23855.r83">[83]</xref> Topical voriconazole<bold>&#x000a0;</bold>(1%)&#x000a0;is added as an adjunct to natamycin in&#x000a0;<italic toggle="yes">Aspergillus&#x000a0;</italic>keratitis, not responding to natamycin alone. Voriconazole is not given as a primary drug for fungal keratitis.<xref ref-type="bibr" rid="article-23855.r83">[83]</xref>&#x000a0;Systemic anti-fungal is added for large and deep corneal ulcers.&#x000a0;As per the MUTT II trial,&#x000a0;the use of oral voriconazole does not make a significant difference compared to placebo in severe fungal keratitis.<xref ref-type="bibr" rid="article-23855.r84">[84]</xref>&#x000a0;However, it had some role in&#x000a0;<italic toggle="yes">Fusarium</italic> keratitis.<xref ref-type="bibr" rid="article-23855.r85">[85]</xref>&#x000a0;Repeated superficial corneal ulcer debridement is an important component of treatment. Repeated debridement not only decreases fungal load but also facilitates penetration of hydrophilic natamycin into the corneal stroma. The role&#x000a0;of intrastromal voriconazole for non-responding lesions cannot be ignored.<xref ref-type="bibr" rid="article-23855.r86">[86]</xref>&#x000a0;Topical amphotericin-B (0.15%) is the drug of choice in candida keratitis. Therapeutic penetrating keratoplasty is indicated in keratitis threatening limbus or perforated corneal ulcer not amenable to tissue adhesive application.</p>
        <p>
<bold>Viral Keratitis</bold>
</p>
        <p>Dual staining with Rose-Bengal and fluorescein stain is a very important clinical tool to make a diagnosis of HSV epithelial disease. Fluorescein stain makes the dendrites and geographical ulcers more evident by staining the base of the ulcer, and Rose-Bengal stains the&#x000a0;cells at the margin of the ulcer,&#x000a0;which are loaded with viruses. The diagnosis of epithelial disease is mostly clinical.<xref ref-type="bibr" rid="article-23855.r87">[87]</xref>&#x000a0;Corneal scraping for polymerase chain reaction&#x000a0;for HSV viral DNA is done in doubtful cases.<xref ref-type="bibr" rid="article-23855.r88">[88]</xref>&#x000a0;Topical antiviral (acyclovir 3%- 5 times a day)&#x000a0;is the mainstay of treatment for epithelial disease.<xref ref-type="bibr" rid="article-23855.r27">[27]</xref> For HSV stromal disease and endotheliitis, a topical steroid is the mainstay of treatment. However, oral antiviral (acyclovir 400 mg, 5 times daily) is also added to prevent further recurrence.<xref ref-type="bibr" rid="article-23855.r89">[89]</xref>&#x000a0;For HSV necrotizing stromal keratitis, treatment has to be given at the earliest to avoid corneal melt and subsequent perforation. The loading dose of antiviral both topical acyclovir (3%)<bold>&#x000a0;</bold>and oral (acyclovir 400 mg 5 times daily ) is given for the initial three days.<xref ref-type="bibr" rid="article-23855.r31">[31]</xref> Topical steroid is added on the third day. For cases presenting as severe thinning or perforation, tissue adhesive (cyanoacrylate glue) and bandage contact lens are applied. Preferably, a topical steroid is started after applying tissue adhesive to avoid steroid-induced further stromal lysis.&#x000a0;For recurrent HSV keratitis, a prophylactic dose of oral antiviral (acyclovir 400 mg twice daily) is given for a year.<xref ref-type="bibr" rid="article-23855.r90">[90]</xref></p>
        <p>The diagnosis of HZO is clinical. The skin lesions associated with corneal dendritiform lesions are very characteristic. Unlike chickenpox lesions, the skin lesions are in the same stage. The ends of dendritiform lesions are tapering, unlike in dendritic ulcers in HSV epithelial keratitis. The pseudodendrites are because of swollen epithelial cells, so they do not take up fluorescein stain. Oral acyclovir (800 mg, 5 times daily for 1 week)&#x000a0;is very effective in its treatment in the early stages.<xref ref-type="bibr" rid="article-23855.r91">[91]</xref> The recurrent epithelial erosions should largely be managed with lubricants and prophylactic antibiotics. Neurotrophic ulcers are managed with serum, amniotic membrane transplantation, and tarsorrhaphy. The role of long term prophylaxis with oral antivirals is not clear and needs to be evaluated.<xref ref-type="bibr" rid="article-23855.r92">[92]</xref></p>
        <p>Adenoviral keratitis: The diagnosis of adenoviral keratoconjunctivitis is primarily clinical. However, wherever in doubt, it can be confirmed using PCR techniques. Considering the contagious nature of the disease, maintenance of personal hygiene has a very important role in preventing its transmission. Topical 1% povidone-iodine, in combination with 0.1% dexamethasone, has shown good results.<xref ref-type="bibr" rid="article-23855.r93">[93]</xref>&#x000a0;The role of steroids in the early stages is controversial.<xref ref-type="bibr" rid="article-23855.r20">[20]</xref>. Topical cyclosporine 2%, when added in the acute stage in combination with topical steroids, resulted in inhibition of subepithelial infiltrates.<xref ref-type="bibr" rid="article-23855.r94">[94]</xref>&#x000a0;</p>
        <p>
<bold>Non-infectious Keratitis</bold>
</p>
        <p>
<bold>Local Causes</bold>
</p>
        <p>Patients with ulcers related to trichiatic lashes, entropion, or distichiasis need early correction of pathology. The diagnosis is largely clinical. Either electrolysis of eyelash hair root follicle, lid everting procedures, or lid splitting procedures, respectively, need to be done without compromising the gross anatomical relationship.<xref ref-type="bibr" rid="article-23855.r95">[95]</xref><xref ref-type="bibr" rid="article-23855.r96">[96]</xref></p>
        <p>Shield ulcer is an ulcer due to the mechanical effect of giant papillae. Diagnosis is obvious on lid eversion. Topical steroids, along with topical cyclosporine<bold>&#x000a0;(</bold>0.05%) and lubricants, are sufficient enough to control the disease.<xref ref-type="bibr" rid="article-23855.r97">[97]</xref> Control of ocular allergy itself helps improve shield ulcers. Supratarsal triamcinolone injection in refractory cases helps.<xref ref-type="bibr" rid="article-23855.r98">[98]</xref>&#x000a0;However, surgical excision of giant papillae and conjunctival autologous graft or mucous membrane graft has also been described in refractory cases.<xref ref-type="bibr" rid="article-23855.r99">[99]</xref><xref ref-type="bibr" rid="article-23855.r100">[100]</xref><xref ref-type="bibr" rid="article-23855.r95">[95]</xref></p>
        <p>Patients with corneal ulcers related to sulcus subtarsalis foreign body needs immediate removal of a foreign body under topical anesthesia either on slit lamp or under the microscope in the operating room.</p>
        <p>
<bold>Systemic Causes</bold>
</p>
        <p>Rheumatoid arthritis: The diagnosis is largely by serological methods; however, clinical findings like finger deformities are suggestive. RA factor and anti-cyclic citrullinated peptide&#x000a0;antibodies (anti-CCP) are important serological markers.<xref ref-type="bibr" rid="article-23855.r57">[57]</xref> Anti- CCP antibodies help in making an early diagnosis.<xref ref-type="bibr" rid="article-23855.r57">[57]</xref><xref ref-type="bibr" rid="article-23855.r101">[101]</xref><xref ref-type="bibr" rid="article-23855.r102">[102]</xref>&#x000a0;The cause of keratitis is immunological. Topical and oral steroids are the mainstay of initial treatments. The patient is started on oral or subcutaneous methotrexate (steroid-sparing agent) under the rheumatologist's supervision.<xref ref-type="bibr" rid="article-23855.r103">[103]</xref>&#x000a0;Perforated corneal ulcers are managed either with cyanoacrylate glue or a multi-layered amniotic membrane graft, provided the perforation is amenable to closure.<xref ref-type="bibr" rid="article-23855.r104">[104]</xref><xref ref-type="bibr" rid="article-23855.r105">[105]</xref>&#x000a0;For large perforations, either a corneal patch graft or penetrating keratoplasty with simultaneous immunosuppression is done.<xref ref-type="bibr" rid="article-23855.r57">[57]</xref></p>
        <p>Granulomatosis with polyangiitis:&#x000a0;The clinical features are suggestive; however, the serological test is diagnostic. C-ANCA is the serological marker.<xref ref-type="bibr" rid="article-23855.r106">[106]</xref>&#x000a0;GPA not only adds to the morbidity but is a life-threatening condition if left untreated.<xref ref-type="bibr" rid="article-23855.r106">[106]</xref> So, early diagnosis and initiation of treatment at the earliest are important. Routine urine examination is also important to look for renal involvement at the presentation&#x02014;earlier, the renal involvement poorer the prognosis. Pulse cyclophosphamide is the drug of choice.<xref ref-type="bibr" rid="article-23855.r106">[106]</xref> Topical steroids, along with oral immunosuppressive (steroids), can be used to treat peripheral ulcerative keratitis.&#x000a0;</p>
        <p>Xerophthalmia: Vitamin A supplementation, as per WHO guidelines, needs to be done at the earliest.&#x000a0;</p>
        <p>Some patients do&#x000a0;require surgical interventions, like the application of tissue adhesives, amniotic membrane transplantation, patch graft, or penetrating keratoplasty, to maintain the integrity of the globe. This holds for all keratitis, reaching a fate of severe corneal thinning or perforation.&#x000a0;Therapeutic penetrating keratoplasty is planned for limbus threatening infective keratitis.&#x000a0;</p>
        <p>Apart from various diagnostic and treatment modalities discussed above, now nanoparticles and antimicrobial peptides are being devised for sustained and targeted drug delivery.<xref ref-type="bibr" rid="article-23855.r107">[107]</xref><xref ref-type="bibr" rid="article-23855.r108">[108]</xref>&#x000a0;In addition to&#x000a0;PCR, genotyping, and confocal microscopy, many other modalities are being worked on.</p>
      </sec>
      <sec id="article-23855.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Making a diagnosis of keratitis is not difficult; however, finding the etiology is not always easy. Many times, the direct microscopy and culture reports are unremarkable, and the patient has to be treated based on clinical findings. In the early stages, Acanthamoeba keratitis and HSV stromal keratitis are often indistinguishable; however, the late stages of Acanthamoeba keratitis may simulate fungal keratitis.</p>
        <list list-type="bullet">
          <list-item>
            <p>Atopic keratoconjunctivitis</p>
          </list-item>
          <list-item>
            <p>Bacterial endophthalmitis</p>
          </list-item>
          <list-item>
            <p>Band keratopathy</p>
          </list-item>
          <list-item>
            <p>Blepharitis</p>
          </list-item>
          <list-item>
            <p>Corneal ulcer</p>
          </list-item>
          <list-item>
            <p>Entropion</p>
          </list-item>
          <list-item>
            <p>Epidemic keratoconjunctivitis</p>
          </list-item>
          <list-item>
            <p>Fungal keratitis</p>
          </list-item>
          <list-item>
            <p>Herpes simplex virus keratitis</p>
          </list-item>
          <list-item>
            <p>Herpes zoster</p>
          </list-item>
          <list-item>
            <p>Interstitial keratitis</p>
          </list-item>
          <list-item>
            <p>Neurotrophic keratitis</p>
          </list-item>
          <list-item>
            <p>Nasolacrimal duct obstruction</p>
          </list-item>
          <list-item>
            <p>Ocular rosacea</p>
          </list-item>
          <list-item>
            <p>Pseudophakic bullous keratopathy</p>
          </list-item>
          <list-item>
            <p>Scleritis</p>
          </list-item>
          <list-item>
            <p>Viral conjunctivitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23855.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Overall, corneal ulcers take longer to heal. Bacterial ulcers heal relatively earlier than fungal ulcers, and&#x000a0;<italic toggle="yes">Acanthamoeba&#x000a0;</italic>keratitis might take months for complete remission. Corneal scarring is the most common outcome following corneal ulcers. These cases can be managed later with glasses, optical iridectomy, or optical keratoplasty to restore vision. Perforated corneal ulcers often tend to have a worse prognosis. The use of prior topical steroids in fungal and&#x000a0;<italic toggle="yes">Acanthamoeba</italic> keratitis worsens the prognosis.</p>
      </sec>
      <sec id="article-23855.s12" sec-type="Complications">
        <title>Complications</title>
        <p>
<bold>Complications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Toxic iridocyclitis</p>
          </list-item>
          <list-item>
            <p>Secondary glaucoma</p>
          </list-item>
          <list-item>
            <p>Descemetocele</p>
          </list-item>
          <list-item>
            <p>Perforation of corneal ulcer</p>
          </list-item>
        </list>
        <p>
<bold>Sequelae of Corneal Perforation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Iris prolapse</p>
          </list-item>
          <list-item>
            <p>Anterior dislocation of the lens</p>
          </list-item>
          <list-item>
            <p>Anterior capsular cataract</p>
          </list-item>
          <list-item>
            <p>Corneal fistula</p>
          </list-item>
          <list-item>
            <p>Purulent uveitis</p>
          </list-item>
          <list-item>
            <p>Intraocular hemorrhage</p>
          </list-item>
          <list-item>
            <p>Corneal scarring- nebula, macula, leucoma, adherent leucoma</p>
          </list-item>
          <list-item>
            <p>Keratectasia</p>
          </list-item>
          <list-item>
            <p>Disorganized anterior chamber</p>
          </list-item>
          <list-item>
            <p>Autoevisceration</p>
          </list-item>
          <list-item>
            <p>Phthisis bulbi</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23855.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Considering the majority of cases of keratitis due to agricultural trauma in developing nations, it is advisable to use eyeshields during harvest season in fields. Apart from these, cases with recurrent HSV keratitis (more than 3 episodes in a year) should take oral antiviral prophylaxis for 1 year.<xref ref-type="bibr" rid="article-23855.r90">[90]</xref></p>
      </sec>
      <sec id="article-23855.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>To conclude, comprehensive treatment for keratitis would be first to find the etiology using various clinical and/or microbiological findings and serological markers and then to address it. It can be addressed with topical and/or systemic drugs. In the case where globe integrity is compromised, measures like tissue adhesive application, amniotic membrane transplantation, patch graft, or penetrating keratoplasty are done. Each treatment modality has to be tailored as per the requirement. This article tries to bring out a comprehensive idea about keratitis and its management.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-23855.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>It is always good to have an inhouse microbiologist so that reporting of direct smears can be done at the earliest. Ophthalmologist and a rheumatologist should also work hand in hand. Many patients are referred to a rheumatologist by an ophthalmologist for systemic evaluation and starting immunomodulators. The patients need to follow at both places. An ophthalmologist can suggest a rheumatologist for titrating the dose of immunomodulators based on clinical response. Apart from these, patients are also&#x000a0;evaluated for any adverse effect profile. These kinds of work models not only ensure better clinical outcomes and patient safety but also a healthy work atmosphere.</p>
      </sec>
      <sec id="article-23855.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23855&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23855">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/keratitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23855">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23855/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23855">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23855.s17">
        <title>References</title>
        <ref id="article-23855.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tjia</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>van Putten</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Pels</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zanen</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>The interaction between Neisseria gonorrhoeae and the human cornea in organ culture. An electron microscopic study.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>1988</year>
            <volume>226</volume>
            <issue>4</issue>
            <fpage>341</fpage>
            <page-range>341-5</page-range>
            <pub-id pub-id-type="pmid">3139497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendoza</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ajello</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Life cycle of the human and animal oomycete pathogen Pythium insidiosum.</article-title>
            <source>J Clin Microbiol</source>
            <year>1993</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>2967</fpage>
            <page-range>2967-73</page-range>
            <pub-id pub-id-type="pmid">8263182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tondolo</surname>
                <given-names>JSM</given-names>
              </name>
              <name>
                <surname>Ledur</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Loreto</surname>
                <given-names>&#x000c9;S</given-names>
              </name>
              <name>
                <surname>Verdi</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bitencourt</surname>
                <given-names>PER</given-names>
              </name>
              <name>
                <surname>de Jesus</surname>
                <given-names>FPK</given-names>
              </name>
              <name>
                <surname>Rocha</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Alves</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Sassaki</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Santurio</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Extraction, characterization and biological activity of a (1,3)(1,6)-&#x003b2;-d-glucan from the pathogenic oomycete Pythium insidiosum.</article-title>
            <source>Carbohydr Polym</source>
            <year>2017</year>
            <month>Feb</month>
            <day>10</day>
            <volume>157</volume>
            <fpage>719</fpage>
            <page-range>719-727</page-range>
            <pub-id pub-id-type="pmid">27987983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ladas</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Mondino</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Systemic disorders associated with peripheral corneal ulceration.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>468</fpage>
            <page-range>468-71</page-range>
            <pub-id pub-id-type="pmid">11141643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeng</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Gritz</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Holsclaw</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Porco</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Whitcher</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Margolis</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>IG</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of ulcerative keratitis in Northern California.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>128</volume>
            <issue>8</issue>
            <fpage>1022</fpage>
            <page-range>1022-8</page-range>
            <pub-id pub-id-type="pmid">20697003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Srinivasan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gonzales</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cevallos</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mascarenhas</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Asokan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wilkins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smolin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Whitcher</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>81</volume>
            <issue>11</issue>
            <fpage>965</fpage>
            <page-range>965-71</page-range>
            <pub-id pub-id-type="pmid">9505820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hill</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Ku</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Dwarakanathan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Herpes simplex keratitis.</article-title>
            <source>Dis Mon</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>60</volume>
            <issue>6</issue>
            <fpage>239</fpage>
            <page-range>239-46</page-range>
            <pub-id pub-id-type="pmid">24906668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liesegang</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1989</year>
            <month>Aug</month>
            <volume>107</volume>
            <issue>8</issue>
            <fpage>1160</fpage>
            <page-range>1160-5</page-range>
            <pub-id pub-id-type="pmid">2757546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Scleritis and peripheral ulcerative keratitis.</article-title>
            <source>Rheum Dis Clin North Am</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>835</fpage>
            <page-range>835-54, vii</page-range>
            <pub-id pub-id-type="pmid">18037120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Shirefaw</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Tomkins-Netzer</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Eshete</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Netzer-Tomkins</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ben-Zion</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of xerophthalmia among malnourished children in rural Ethiopia.</article-title>
            <source>Int Ophthalmol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>455</fpage>
            <page-range>455-9</page-range>
            <pub-id pub-id-type="pmid">23354453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kenyon</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Inflammatory mechanisms in corneal ulceration.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1985</year>
            <volume>83</volume>
            <fpage>610</fpage>
            <page-range>610-63</page-range>
            <pub-id pub-id-type="pmid">3914132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chigbu</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Labib</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis and management of adenoviral keratoconjunctivitis.</article-title>
            <source>Infect Drug Resist</source>
            <year>2018</year>
            <volume>11</volume>
            <fpage>981</fpage>
            <page-range>981-993</page-range>
            <pub-id pub-id-type="pmid">30046247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dana</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Qian</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hamrah</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection.</article-title>
            <source>Cornea</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>625</fpage>
            <page-range>625-43</page-range>
            <pub-id pub-id-type="pmid">11009315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeCroos</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krishnaiah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mungale</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mruthyunjaya</surname>
                <given-names>P</given-names>
              </name>
              <collab>Hyderabad Endophthalmitis Research Group</collab>
            </person-group>
            <article-title>Optimizing diagnosis and management of nocardia keratitis, scleritis, and endophthalmitis: 11-year microbial and clinical overview.</article-title>
            <source>Ophthalmology</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>118</volume>
            <issue>6</issue>
            <fpage>1193</fpage>
            <page-range>1193-200</page-range>
            <pub-id pub-id-type="pmid">21276615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sridhar</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Gopinathan</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Ocular nocardia infections with special emphasis on the cornea.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2001</year>
            <season>Mar-Apr</season>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>361</fpage>
            <page-range>361-78</page-range>
            <pub-id pub-id-type="pmid">11274691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Yong</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TI</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>96</volume>
            <issue>51</issue>
            <fpage>e9356</fpage>
            <pub-id pub-id-type="pmid">29390522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>John</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Velotta</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous (atypical) mycobacterial keratitis after LASIK: current status and clinical implications.</article-title>
            <source>Cornea</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>245</fpage>
            <page-range>245-55</page-range>
            <pub-id pub-id-type="pmid">15778593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moorthy</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Valluri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous mycobacterial ocular and adnexal infections.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2012</year>
            <season>May-Jun</season>
            <volume>57</volume>
            <issue>3</issue>
            <fpage>202</fpage>
            <page-range>202-35</page-range>
            <pub-id pub-id-type="pmid">22516536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kheir</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Sheheitli</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abdul Fattah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hamam</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature.</article-title>
            <source>Biomed Res Int</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>164989</fpage>
            <pub-id pub-id-type="pmid">26106601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Omari</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Mian</surname>
                <given-names>SI</given-names>
              </name>
            </person-group>
            <article-title>Adenoviral keratitis: a review of the epidemiology, pathophysiology, clinical features, diagnosis, and management.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>365</fpage>
            <page-range>365-372</page-range>
            <pub-id pub-id-type="pmid">29708932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mader</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Stulting</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Viral keratitis.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>1992</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>831</fpage>
            <page-range>831-49</page-range>
            <pub-id pub-id-type="pmid">1334105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bialasiewicz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Adenoviral keratoconjunctivitis.</article-title>
            <source>Sultan Qaboos Univ Med J</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-23</page-range>
            <pub-id pub-id-type="pmid">21654940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akkaya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ozkurt</surname>
                <given-names>YB</given-names>
              </name>
            </person-group>
            <article-title>Persistent Symblepharon in an Infant Following Epidemic Keratoconjunctivitis.</article-title>
            <source>Med Hypothesis Discov Innov Ophthalmol</source>
            <year>2016</year>
            <season>Fall</season>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>74</fpage>
            <page-range>74-77</page-range>
            <pub-id pub-id-type="pmid">28293652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hammer</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Donnenfeld</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Rahn</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>Symblepharon formation in epidemic keratoconjunctivitis.</article-title>
            <source>Cornea</source>
            <year>1990</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>338</fpage>
            <page-range>338-40</page-range>
            <pub-id pub-id-type="pmid">2078963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shoji</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sakimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Inada</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kamei</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsubara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takamura</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A diagnostic method for herpes simplex keratitis by simultaneous measurement of viral DNA and virus-specific secretory IgA in tears: an evaluation.</article-title>
            <source>Jpn J Ophthalmol</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>60</volume>
            <issue>4</issue>
            <fpage>294</fpage>
            <page-range>294-301</page-range>
            <pub-id pub-id-type="pmid">27126382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Dreyer</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Herpesvirus infections of the anterior segment.</article-title>
            <source>Int Ophthalmol Clin</source>
            <year>1996</year>
            <season>Summer</season>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>17</fpage>
            <page-range>17-28</page-range>
            <pub-id pub-id-type="pmid">8989597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilhelmus</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Jan</month>
            <day>09</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD002898</fpage>
            <pub-id pub-id-type="pmid">25879115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Souza</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Bilateral herpetic keratoconjunctivitis.</article-title>
            <source>Ophthalmology</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>110</volume>
            <issue>3</issue>
            <fpage>493</fpage>
            <page-range>493-6</page-range>
            <pub-id pub-id-type="pmid">12623810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holbach</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Font</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Naumann</surname>
                <given-names>GO</given-names>
              </name>
            </person-group>
            <article-title>Herpes simplex stromal and endothelial keratitis. Granulomatous cell reactions at the level of Descemet's membrane, the stroma, and Bowman's layer.</article-title>
            <source>Ophthalmology</source>
            <year>1990</year>
            <month>Jun</month>
            <volume>97</volume>
            <issue>6</issue>
            <fpage>722</fpage>
            <page-range>722-8</page-range>
            <pub-id pub-id-type="pmid">2165231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGill</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The enigma of herpes stromal disease.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1987</year>
            <month>Feb</month>
            <volume>71</volume>
            <issue>2</issue>
            <fpage>118</fpage>
            <page-range>118-25</page-range>
            <pub-id pub-id-type="pmid">3548807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dutt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Acharya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sapra</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mathur</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Clinical efficacy of oral and topical acyclovir in herpes simplex virus stromal necrotizing keratitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>292</fpage>
            <page-range>292-5</page-range>
            <pub-id pub-id-type="pmid">27221681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalogeropoulos</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Bassukas</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Moschos</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Tabbara</surname>
                <given-names>KF</given-names>
              </name>
            </person-group>
            <article-title>Eye and Periocular Skin Involvement in Herpes Zoster Infection.</article-title>
            <source>Med Hypothesis Discov Innov Ophthalmol</source>
            <year>2015</year>
            <season>Winter</season>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>142</fpage>
            <page-range>142-156</page-range>
            <pub-id pub-id-type="pmid">27800502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Herpes zoster ophthalmicus: acute keratitis.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>328</fpage>
            <page-range>328-333</page-range>
            <pub-id pub-id-type="pmid">29794881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Margolis</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>149</volume>
            <issue>2</issue>
            <fpage>214</fpage>
            <page-range>214-220.e3</page-range>
            <pub-id pub-id-type="pmid">19909942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Sheppard</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Herpes Zoster Ophthalmicus Review and Prevention.</article-title>
            <source>Eye Contact Lens</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>286</fpage>
            <page-range>286-291</page-range>
            <pub-id pub-id-type="pmid">30844951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maycock</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Jayaswal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes.</article-title>
            <source>Cornea</source>
            <year>2016</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>713</fpage>
            <page-range>713-20</page-range>
            <pub-id pub-id-type="pmid">26989955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lorenzo-Morales</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Walochnik</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.</article-title>
            <source>Parasite</source>
            <year>2015</year>
            <volume>22</volume>
            <fpage>10</fpage>
            <pub-id pub-id-type="pmid">25687209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Balne</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Motukupally</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sahu</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Arunasri</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Manjulatha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Shivaji</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pythium insidiosum keratitis: clinical profile and role of DNA sequencing and zoospore formation in diagnosis.</article-title>
            <source>Cornea</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>438</fpage>
            <page-range>438-42</page-range>
            <pub-id pub-id-type="pmid">25738236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vossbrinck</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Maddox</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Debrunner-Vossbrinck</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Woese</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Ribosomal RNA sequence suggests microsporidia are extremely ancient eukaryotes.</article-title>
            <source>Nature</source>
            <string-date>1987 Mar 26-Apr 1</string-date>
            <volume>326</volume>
            <issue>6111</issue>
            <fpage>411</fpage>
            <page-range>411-4</page-range>
            <pub-id pub-id-type="pmid">3550472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Edlind</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Vossbrinck</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Microsporidian molecular phylogeny: the fungal connection.</article-title>
            <source>J Eukaryot Microbiol</source>
            <year>1999</year>
            <season>Sep-Oct</season>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>17S</fpage>
            <page-range>17S-18S</page-range>
            <pub-id pub-id-type="pmid">10519229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Capella-Guti&#x000e9;rrez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marcet-Houben</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gabald&#x000f3;n</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.</article-title>
            <source>BMC Biol</source>
            <year>2012</year>
            <month>May</month>
            <day>31</day>
            <volume>10</volume>
            <fpage>47</fpage>
            <pub-id pub-id-type="pmid">22651672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sridhar</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Microsporidial keratoconjunctivitis in a HIV-seronegative patient treated with debridement and oral itraconazole.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>136</volume>
            <issue>4</issue>
            <fpage>745</fpage>
            <page-range>745-6</page-range>
            <pub-id pub-id-type="pmid">14516821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joseph</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sridhar</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Murthy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical and microbiological profile of microsporidial keratoconjunctivitis in southern India.</article-title>
            <source>Ophthalmology</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>113</volume>
            <issue>4</issue>
            <fpage>531</fpage>
            <page-range>531-7</page-range>
            <pub-id pub-id-type="pmid">16488011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moon</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Matoba</surname>
                <given-names>AY</given-names>
              </name>
            </person-group>
            <article-title>Microsporidial keratoconjunctivitis in a healthy patient with a history of LASIK surgery.</article-title>
            <source>Cornea</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>271</fpage>
            <page-range>271-2</page-range>
            <pub-id pub-id-type="pmid">12658099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sahu</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Nayak</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>New microbial spectrum of epidemic keratoconjunctivitis: clinical and laboratory aspects of an outbreak.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>92</volume>
            <issue>6</issue>
            <fpage>861</fpage>
            <page-range>861-2</page-range>
            <pub-id pub-id-type="pmid">18523092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reddy</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Balne</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Krishnaiah</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Is microsporidial keratitis a seasonal infection in India?</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>7</issue>
            <fpage>1114</fpage>
            <page-range>1114-6</page-range>
            <pub-id pub-id-type="pmid">21726353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loh</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Ti</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>DT</given-names>
              </name>
            </person-group>
            <article-title>Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management.</article-title>
            <source>Ophthalmology</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>116</volume>
            <issue>12</issue>
            <fpage>2348</fpage>
            <page-range>2348-53</page-range>
            <pub-id pub-id-type="pmid">19815287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tung-Lien Quek</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>PU</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Teoh</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Microsporidial keratoconjunctivitis in the tropics: a case series.</article-title>
            <source>Open Ophthalmol J</source>
            <year>2011</year>
            <volume>5</volume>
            <fpage>42</fpage>
            <page-range>42-7</page-range>
            <pub-id pub-id-type="pmid">21643428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinnolis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Egbert</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Font</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Nosematosis of the cornea. Case report, including electron microscopic studies.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1981</year>
            <month>Jun</month>
            <volume>99</volume>
            <issue>6</issue>
            <fpage>1044</fpage>
            <page-range>1044-7</page-range>
            <pub-id pub-id-type="pmid">6786272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vemuganti</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gopinathan</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Is microsporidial keratitis an emerging cause of stromal keratitis? A case series study.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2005</year>
            <month>Aug</month>
            <day>17</day>
            <volume>5</volume>
            <fpage>19</fpage>
            <pub-id pub-id-type="pmid">16105181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Fong</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>DT</given-names>
              </name>
            </person-group>
            <article-title>Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study.</article-title>
            <source>CLAO J</source>
            <year>1997</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>275</fpage>
            <page-range>275-81</page-range>
            <pub-id pub-id-type="pmid">9348453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lalitha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Prajna</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Kabra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mahadevan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for treatment outcome in fungal keratitis.</article-title>
            <source>Ophthalmology</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>113</volume>
            <issue>4</issue>
            <fpage>526</fpage>
            <page-range>526-30</page-range>
            <pub-id pub-id-type="pmid">16581414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gopinathan</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Choudhary</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Keratomycosis: clinical and microbiologic experience with dematiaceous fungi.</article-title>
            <source>Ophthalmology</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>107</volume>
            <issue>3</issue>
            <fpage>574</fpage>
            <page-range>574-80</page-range>
            <pub-id pub-id-type="pmid">10711898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rice</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>BR</given-names>
              </name>
            </person-group>
            <article-title>Vernal kerato-conjunctivitis: an allergic disease of the eyes of children.</article-title>
            <source>Clin Allergy</source>
            <year>1973</year>
            <month>Dec</month>
            <volume>3 Suppl</volume>
            <fpage>629</fpage>
            <page-range>629-37</page-range>
            <pub-id pub-id-type="pmid">4220246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhalerao</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rani</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Rathi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The sting of a honey bee: An unusual subconjunctival foreign body.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>65</volume>
            <issue>11</issue>
            <fpage>1226</fpage>
            <page-range>1226-1228</page-range>
            <pub-id pub-id-type="pmid">29133661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Itty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pulido</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Bakri</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Baratz</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Matteson</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>DO</given-names>
              </name>
            </person-group>
            <article-title>Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>2008</year>
            <volume>106</volume>
            <fpage>75</fpage>
            <page-range>75-81; discussion 81-3</page-range>
            <pub-id pub-id-type="pmid">19277223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>68</volume>
            <issue>1</issue>
            <fpage>236</fpage>
            <page-range>236-238</page-range>
            <pub-id pub-id-type="pmid">31856537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bullen</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Liesegang</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>DeRemee</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Ocular complications of Wegener's granulomatosis.</article-title>
            <source>Ophthalmology</source>
            <year>1983</year>
            <month>Mar</month>
            <volume>90</volume>
            <issue>3</issue>
            <fpage>279</fpage>
            <page-range>279-90</page-range>
            <pub-id pub-id-type="pmid">6602963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment.</article-title>
            <source>J Ophthalmol</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>7298026</fpage>
            <pub-id pub-id-type="pmid">28785483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x00158;&#x000ed;hov&#x000e1;</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Svoz&#x000ed;lkov&#x000e1;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brichov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kl&#x000ed;mov&#x000e1;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kuthan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dibl&#x000ed;k</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Ocular Manifestations of Granulomatosis with Polyangiitis.</article-title>
            <source>Cesk Slov Oftalmol</source>
            <year>2019</year>
            <season>Spring</season>
            <volume>74</volume>
            <issue>5</issue>
            <fpage>167</fpage>
            <page-range>167-174</page-range>
            <pub-id pub-id-type="pmid">31234629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bluestone</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Bridge collapse followed by joint pains, nephritis.</article-title>
            <source>Hosp Pract (Off Ed)</source>
            <year>1983</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>58L</fpage>
            <page-range>58L, 58P</page-range>
            <pub-id pub-id-type="pmid">6409795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khor</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Prajna</surname>
                <given-names>VN</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Padilla</surname>
                <given-names>MDB</given-names>
              </name>
              <name>
                <surname>Joo</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Goseyarakwong</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kinoshita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Puangsricharern</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Beuerman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Haaland</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mah</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Stapleton</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Abbott</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>DT</given-names>
              </name>
              <collab>ACSIKS Group</collab>
            </person-group>
            <article-title>The Asia Cornea Society Infectious Keratitis Study: A Prospective Multicenter Study of Infectious Keratitis in Asia.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>195</volume>
            <fpage>161</fpage>
            <page-range>161-170</page-range>
            <pub-id pub-id-type="pmid">30098351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tandon</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Investigative modalities in infectious keratitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2008</year>
            <season>May-Jun</season>
            <volume>56</volume>
            <issue>3</issue>
            <fpage>209</fpage>
            <page-range>209-13</page-range>
            <pub-id pub-id-type="pmid">18417821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Investigative modalities in infectious keratitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2009</year>
            <season>Mar-Apr</season>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>159</fpage>
            <pub-id pub-id-type="pmid">19237797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>287</fpage>
            <page-range>287-92</page-range>
            <pub-id pub-id-type="pmid">15693319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McElvanney</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Doxycycline in the management of pseudomonas corneal melting: two case reports and a review of the literature.</article-title>
            <source>Eye Contact Lens</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>258</fpage>
            <page-range>258-61</page-range>
            <pub-id pub-id-type="pmid">14555906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chatterjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-7</page-range>
            <pub-id pub-id-type="pmid">27050354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Fungal, Mycobacterial, and Nocardia infections and the eye: an update.</article-title>
            <source>Eye (Lond)</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>245</fpage>
            <page-range>245-51</page-range>
            <pub-id pub-id-type="pmid">22173077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sridhar</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Mruthyunjay</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Clinicomicrobiological review of Nocardia keratitis.</article-title>
            <source>Cornea</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-22</page-range>
            <pub-id pub-id-type="pmid">9436875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lalitha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rajaraman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ravindran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mascarenhas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Priya</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Sy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oldenburg</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Zegans</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Lietman</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Acharya</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Nocardia keratitis: clinical course and effect of corticosteroids.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>154</volume>
            <issue>6</issue>
            <fpage>934</fpage>
            <page-range>934-939.e1</page-range>
            <pub-id pub-id-type="pmid">22959881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lorenzo-Morales</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n-Navarro</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Arencibia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arnalich-Montiel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pi&#x000f1;ero</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Valladares</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba keratitis: an emerging disease gathering importance worldwide?</article-title>
            <source>Trends Parasitol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>181</fpage>
            <page-range>181-7</page-range>
            <pub-id pub-id-type="pmid">23433689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tu</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Shoff</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Joslin</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Effect of low concentrations of benzalkonium chloride on acanthamoebal survival and its potential impact on empirical therapy of infectious keratitis.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2013</year>
            <month>May</month>
            <volume>131</volume>
            <issue>5</issue>
            <fpage>595</fpage>
            <page-range>595-600</page-range>
            <pub-id pub-id-type="pmid">23519403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakagawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koike</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ehara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Narimatsu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumakura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Number of Bacteria and Time of Coincubation With Bacteria Required for the Development of Acanthamoeba Keratitis.</article-title>
            <source>Cornea</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>353</fpage>
            <page-range>353-357</page-range>
            <pub-id pub-id-type="pmid">28079686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakagawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koike</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ehara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kumakura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kuroda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Investigation of the Role of Bacteria in the Development of Acanthamoeba Keratitis.</article-title>
            <source>Cornea</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>34</volume>
            <issue>10</issue>
            <fpage>1308</fpage>
            <page-range>1308-15</page-range>
            <pub-id pub-id-type="pmid">26203748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mittal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jena</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pythium Insidiosum Keratitis: Histopathology and Rapid Novel Diagnostic Staining Technique.</article-title>
            <source>Cornea</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>9</issue>
            <fpage>1124</fpage>
            <page-range>1124-1132</page-range>
            <pub-id pub-id-type="pmid">28582375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramappa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagpal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chaurasia</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Successful Medical Management of Presumptive Pythium insidiosum Keratitis.</article-title>
            <source>Cornea</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>511</fpage>
            <page-range>511-514</page-range>
            <pub-id pub-id-type="pmid">28207431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bagga</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Madhuri Guda</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Nagpal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Manjulatha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Leap forward in the treatment of <italic>Pythium insidiosum</italic> keratitis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>102</volume>
            <issue>12</issue>
            <fpage>1629</fpage>
            <page-range>1629-1633</page-range>
            <pub-id pub-id-type="pmid">29545414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loreto</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Tondolo</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Pilotto</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Alves</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Santurio</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>New insights into the in vitro susceptibility of Pythium insidiosum.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>58</volume>
            <issue>12</issue>
            <fpage>7534</fpage>
            <page-range>7534-7</page-range>
            <pub-id pub-id-type="pmid">25223997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanjay</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical trial of 0.02% polyhexamethylene biguanide versus placebo in the treatment of microsporidial keratoconjunctivitis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>151</volume>
            <issue>1</issue>
            <fpage>183; author reply 183</fpage>
            <pub-id pub-id-type="pmid">21163375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wallang</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhadange</surname>
                <given-names>YV</given-names>
              </name>
              <name>
                <surname>Balne</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Sahu</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>The efficacy of corneal debridement in the treatment of microsporidial keratoconjunctivitis: a prospective randomized clinical trial.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>157</volume>
            <issue>6</issue>
            <fpage>1151</fpage>
            <page-range>1151-5</page-range>
            <pub-id pub-id-type="pmid">24589573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Font</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Samaha</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Keener</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Chevez-Barrios</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Goosey</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Corneal microsporidiosis. Report of case, including electron microscopic observations.</article-title>
            <source>Ophthalmology</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>107</volume>
            <issue>9</issue>
            <fpage>1769</fpage>
            <page-range>1769-75</page-range>
            <pub-id pub-id-type="pmid">10964843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Didier</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Maddry</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Brindley</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Stovall</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Didier</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic strategies for human microsporidia infections.</article-title>
            <source>Expert Rev Anti Infect Ther</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>419</fpage>
            <page-range>419-34</page-range>
            <pub-id pub-id-type="pmid">15954858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prajna</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mascarenhas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rajaraman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Prajna</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raghavan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oldenburg</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Zegans</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Porco</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Acharya</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Lietman</surname>
                <given-names>TM</given-names>
              </name>
              <collab>Mycotic Ulcer Treatment Trial Group</collab>
            </person-group>
            <article-title>The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>131</volume>
            <issue>4</issue>
            <fpage>422</fpage>
            <page-range>422-9</page-range>
            <pub-id pub-id-type="pmid">23710492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prajna</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rajaraman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Oldenburg</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Zegans</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Porco</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Acharya</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Lietman</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Rose-Nussbaumer</surname>
                <given-names>J</given-names>
              </name>
              <collab>Mycotic Ulcer Treatment Trial II Group</collab>
            </person-group>
            <article-title>Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2016</year>
            <month>Dec</month>
            <day>01</day>
            <volume>134</volume>
            <issue>12</issue>
            <fpage>1365</fpage>
            <page-range>1365-1372</page-range>
            <pub-id pub-id-type="pmid">27787540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prajna</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rajaraman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Devi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Oldenburg</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Zegans</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Acharya</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Lietman</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Rose-Nussbaumer</surname>
                <given-names>J</given-names>
              </name>
              <collab>Mycotic Ulcer Treatment Trial Group</collab>
            </person-group>
            <article-title>Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2017</year>
            <month>Jun</month>
            <day>01</day>
            <volume>135</volume>
            <issue>6</issue>
            <fpage>520</fpage>
            <page-range>520-525</page-range>
            <pub-id pub-id-type="pmid">28426856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sahay</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maharana</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Singhal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Saluja</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bandivadekar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chako</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Titiyal</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Satpathy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Velpandian</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Management Algorithm for Fungal Keratitis: The TST (Topical, Systemic, and Targeted Therapy) Protocol.</article-title>
            <source>Cornea</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-145</page-range>
            <pub-id pub-id-type="pmid">30334872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darougar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wishart</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Viswalingam</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Epidemiological and clinical features of primary herpes simplex virus ocular infection.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1985</year>
            <month>Jan</month>
            <volume>69</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-6</page-range>
            <pub-id pub-id-type="pmid">3965025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koizumi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Adachi</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Tei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Honma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dota</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sotozono</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yokoi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kinoshita</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Detection of herpes simplex virus DNA in atypical epithelial keratitis using polymerase chain reaction.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>83</volume>
            <issue>8</issue>
            <fpage>957</fpage>
            <page-range>957-60</page-range>
            <pub-id pub-id-type="pmid">10413702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <article-title>Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>118</volume>
            <issue>8</issue>
            <fpage>1030</fpage>
            <page-range>1030-6</page-range>
            <pub-id pub-id-type="pmid">10922194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis.</article-title>
            <source>Chin Med J (Engl)</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>115</volume>
            <issue>10</issue>
            <fpage>1569</fpage>
            <page-range>1569-72</page-range>
            <pub-id pub-id-type="pmid">12490113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoang-Xuan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>B&#x000fc;chi</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Denis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Th&#x000e9;nault</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pouliquen</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Oral acyclovir for herpes zoster ophthalmicus.</article-title>
            <source>Ophthalmology</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>99</volume>
            <issue>7</issue>
            <fpage>1062</fpage>
            <page-range>1062-70; discussion 1070-1</page-range>
            <pub-id pub-id-type="pmid">1495785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reichstein</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mekaroonkamol</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dacha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Keilin</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Willingham</surname>
                <given-names>FF</given-names>
              </name>
            </person-group>
            <article-title>Practice Patterns and Use of Endoscopic Retrograde Cholangiopancreatography in the Management of Recurrent Acute Pancreatitis.</article-title>
            <source>Clin Endosc</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-81</page-range>
            <pub-id pub-id-type="pmid">31273969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kovalyuk</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kaiserman</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mimouni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Levartovsky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sherbany</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mandelboim</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>95</volume>
            <issue>8</issue>
            <fpage>e686</fpage>
            <page-range>e686-e692</page-range>
            <pub-id pub-id-type="pmid">28342227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>&#x0015e;&#x00131;ngar &#x000d6;zdemir</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Burcu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ercan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>&#x000c7;olak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alt&#x00131;n&#x000f6;rs</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.</article-title>
            <source>Eye (Lond)</source>
            <year>2017</year>
            <month>May</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>781</fpage>
            <page-range>781-787</page-range>
            <pub-id pub-id-type="pmid">28157224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sakarya</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sakarya</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yildirim</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Electrolysis treatment of trichiasis by using ultra-fine needle.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2010</year>
            <season>Jul-Aug</season>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>664</fpage>
            <page-range>664-8</page-range>
            <pub-id pub-id-type="pmid">20037913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Lid splitting and posterior lamella cryosurgery for congenital and acquired distichiasis.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1981</year>
            <month>Apr</month>
            <volume>99</volume>
            <issue>4</issue>
            <fpage>631</fpage>
            <page-range>631-4</page-range>
            <pub-id pub-id-type="pmid">7224935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Combined therapy for vernal shield ulcer.</article-title>
            <source>Clin Exp Optom</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>91</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-4</page-range>
            <pub-id pub-id-type="pmid">18045257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Dhull</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>241</fpage>
            <page-range>241-5</page-range>
            <pub-id pub-id-type="pmid">12930116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishiwaki-Dantas</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Dantas</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Pezzutti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Finzi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Surgical resection of giant papillae and autologous conjunctival graft in patients with severe vernal keratoconjunctivitis and giant papillae.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>438</fpage>
            <page-range>438-42</page-range>
            <pub-id pub-id-type="pmid">11106188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iyer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Outcomes and Rationale of Excision and Mucous Membrane Grafting in Palpebral Vernal Keratoconjunctivitis.</article-title>
            <source>Cornea</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>172</fpage>
            <page-range>172-176</page-range>
            <pub-id pub-id-type="pmid">29040121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Banna</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jiman-Fatani</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.</article-title>
            <source>BMC Musculoskelet Disord</source>
            <year>2014</year>
            <month>Nov</month>
            <day>19</day>
            <volume>15</volume>
            <fpage>379</fpage>
            <pub-id pub-id-type="pmid">25406539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nielen</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>van Schaardenburg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reesink</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>van de Stadt</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>van der Horst-Bruinsma</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>de Koning</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Habibuw</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Vandenbroucke</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Dijkmans</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.</article-title>
            <source>Arthritis Rheum</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>380</fpage>
            <page-range>380-6</page-range>
            <pub-id pub-id-type="pmid">14872479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinblatt</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Methotrexate in rheumatoid arthritis: a quarter century of development.</article-title>
            <source>Trans Am Clin Climatol Assoc</source>
            <year>2013</year>
            <volume>124</volume>
            <fpage>16</fpage>
            <page-range>16-25</page-range>
            <pub-id pub-id-type="pmid">23874006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernauer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ficker</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Dart</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>The management of corneal perforations associated with rheumatoid arthritis. An analysis of 32 eyes.</article-title>
            <source>Ophthalmology</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>102</volume>
            <issue>9</issue>
            <fpage>1325</fpage>
            <page-range>1325-37</page-range>
            <pub-id pub-id-type="pmid">9097770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lohchab</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Prakash</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maharana</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jhanji</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vajpayee</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Surgical management of peripheral corneal thinning disorders.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2019</year>
            <season>Jan-Feb</season>
            <volume>64</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-78</page-range>
            <pub-id pub-id-type="pmid">29886126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarabishy</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Schulte</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Papaliodis</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2010</year>
            <season>Sep-Oct</season>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>429</fpage>
            <page-range>429-44</page-range>
            <pub-id pub-id-type="pmid">20638092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Coupade</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fittipaldi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chagnas</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Michel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carlier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tasciotti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Darmon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ravel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kearsey</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Giacca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cailler</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.</article-title>
            <source>Biochem J</source>
            <year>2005</year>
            <month>Sep</month>
            <day>01</day>
            <volume>390</volume>
            <issue>Pt 2</issue>
            <fpage>407</fpage>
            <page-range>407-18</page-range>
            <pub-id pub-id-type="pmid">15859953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23855.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brandt</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Peptide therapeutics for treating ocular surface infections.</article-title>
            <source>J Ocul Pharmacol Ther</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>9</issue>
            <fpage>691</fpage>
            <page-range>691-9</page-range>
            <pub-id pub-id-type="pmid">25250986</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
